Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report

       
Total article views   HTML views PDF downloads Totals
2,948 Dovepress* 2,698+ 64 2,762
PubMed Central* 250 88 338
Totals 2,948 152 3,100
*Since 23 June 2023

View citations on PubMed Central and Google Scholar